Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Uncovering TK2d: How to Navigate Diagnostic Challenges
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Precision Medicine for Myasthenia Gravis
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
New Therapies, New Strategy: Rethinking MG Inpatient Care
The New Era of Targeted Therapy for Myasthenia Gravis
More Than a Myopathy: The Lived Experience of TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.